Douglas M. Dahl, MD, FACS, discusses the long-term results of post-prostatectomy radiotherapy.
Sequencing Therapy for Metastatic Castration-Resistant Prostate Cancer
November 17th 2021In season 2, episode 9 of Targeted Talks, Sandy Srinivas, MD and Nicholas J. Vogelzang, MD, discuss he optimal sequencing of therapies for a specific patient with metastatic castration-resistant prostate cancer.
Listen
Roundtable Discussion: Yu and Participants Assess the Role of PSMA Therapy for mCRPC
March 3rd 2023During a Targeted Oncology™ Case-Based Roundtable™ event, Evan Y. Yu, MD, discussed with participants role of prostate-specific membrane antigen in metastatic castration-resistant prostate cancer.
Read More
2 Clarke Drive
Cranbury, NJ 08512